BPA Call 36C24821A0031-36C24824K0011
This federal contract award, valued at $65,366.20, was issued by the Department of Veterans Affairs (VA) to Bard Peripheral Vascular, Inc., a subsidiary of Becton, Dickinson and Company (BD), for the supply of vascular surgical stents from January to December 2024. The award is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. There was no set-aside designation used for this contract. Bard Peripheral Vascular, a major manufacturer of implantable medical devices, has held numerous federal contracts and indefinite delivery vehicles with the VA and other agencies, such as the Department of Defense and the Indian Health Service, to provide a wide range of vascular products, including stents, grafts, catheters, and surgical implants. These long-term agreements, some extending into 2027 and 2028, demonstrate Bard's role as a trusted and consistent supplier of essential medical technologies to support federal healthcare programs.
Bard Peripheral Vascular, Inc.
$65.4k 1/8/24 12/10/24 1/8/24 BPA Call 36C24821A0031-36C24823K0022
This is a $72,198.97 Firm Fixed Price contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 8 to Bard Peripheral Vascular, Inc., a subsidiary of Becton, Dickinson and Company (BD), for the delivery of vascular surgical stents from February 2023 through December 2023. The contract was awarded as a BPA Call and does not have a set-aside designation, reflecting Bard Peripheral Vascular's status as a major manufacturer of specialized vascular medical devices. Bard Peripheral Vascular has received numerous federal contract awards from the VA and other agencies to supply a wide range of vascular products, including stents, grafts, catheters, and other implantable devices used to diagnose and treat peripheral vascular disease. As a key supplier of critical medical technologies to support federal healthcare programs, Bard Peripheral Vascular maintains consignment inventory at VA facilities, ensuring the immediate availability of these essential products for patient care.
Bard Peripheral Vascular, Inc.
$72.2k 2/10/23 12/24/23 2/10/23 BPA Call 36C24821A0031-36C24825K0028
This federal contract award was issued by the Veterans Integrated Service Network 8 (VISN 8), a component of the U.S. Department of Veterans Affairs (VA), to Bard Peripheral Vascular, Inc., a subsidiary of Becton, Dickinson and Company (BD). The contract is for the provision of vascular surgical stents for the period of December 2024 to February 2025, with a total ceiling value of $16,377.33. This award is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type. The contract does not have a set-aside designation. Bard Peripheral Vascular is a major supplier of implantable medical devices to the VA and other federal healthcare programs, providing a wide range of vascular products, including stents, grafts, catheters, and accessories used in interventional procedures to diagnose and treat peripheral vascular disease. The company maintains inventory at VA healthcare facilities through consignment arrangements, ensuring the immediate availability of critical medical devices for veterans and other beneficiaries of federal healthcare services.
Bard Peripheral Vascular, Inc.
$16.4k 12/27/24 2/16/25 12/27/24 BPA Call 36C24821A0031-36C24824K0023
This federal contract award is for the supply of vascular surgical stents to the Department of Veterans Affairs (VA) from December 2023 to December 2024. The prime contractor is Bard Peripheral Vascular, Inc., a subsidiary of Becton, Dickinson and Company (BD), a major manufacturer of medical devices. The contract has a ceiling value of $31,896.41 and is a Blanket Purchase Agreement (BPA) Call, with a firm fixed price pricing type. The award was made without a set-aside designation, reflecting Bard Peripheral Vascular's status as a leading provider of vascular products to federal healthcare programs. Bard Peripheral Vascular has established several significant Indefinite Delivery Vehicles (IDVs) with the VA, including BPAs and Indefinite Delivery Contracts (IDCs), which facilitate the ongoing procurement of its vascular devices across VA healthcare networks. These long-term agreements underscore Bard's role as a trusted and consistent supplier of essential medical technologies to support federal healthcare services for veterans and other beneficiaries.
Bard Peripheral Vascular, Inc.
$31.9k 12/5/23 12/22/24 12/5/23 BPA Call 36C24821A0031-36C24822K0021
This federal contract award is for the procurement of vascular surgical stents by the Department of Veterans Affairs (VA) through a Blanket Purchase Agreement (BPA) with Bard Peripheral Vascular, Inc., a subsidiary of Becton, Dickinson and Company (BD). The contract has a ceiling value of $94,219.28 and covers the period from December 2021 to December 2022.
Bard Peripheral Vascular is a major manufacturer of implantable medical devices, specializing in vascular products such as stents, grafts, catheters, and accessories used in interventional procedures. The company has established itself as a trusted supplier of critical vascular technologies to the VA and other federal healthcare agencies. This contract is part of a larger BPA valued at $7.8 million that Bard has with the VA's Veterans Integrated Service Network 8 (VISN 8) for the consignment of vascular stents through September 2025. The contract does not have a set-aside designation, reflecting Bard's status as a leading manufacturer in the medical device industry.
Bard Peripheral Vascular, Inc.
$94.2k 12/22/21 12/23/22 12/22/21